Target intelligence / Profile preview

Signal sequence receptor subunit 1 (SSR1)

Target
SSR1
Molecular classification
Receptor, Translocon-associated protein, Other
01

Overview

Signal sequence receptor subunit 1 is a glycosylated membrane protein located in the endoplasmic reticulum, encoded by the SSR1 gene. It forms part of the signal sequence receptor (SSR) or translocon-associated protein (TRAP) complex—especially as the alpha/SSRA subunit—which plays an essential role in the cotranslational translocation and integration of nascent proteins across the ER membrane. The SSR complex physically associates with the Sec61 protein-conducting channel to facilitate translocation of proteins that contain signal sequences. Beyond its canonical role in protein trafficking, SSR1 is increasingly recognized as a biomarker relevant for cancer prognosis, especially in hepatocellular carcinoma, and is being explored as a potential target for future therapy due to its association with tumor proliferation and immune infiltration[1][2][5][6].

Other names
Translocon-associated protein subunit alphaSignal sequence receptor alpha subunitTRAPASSRASSR alpha
02

Mechanism of action

Inhibition of SSR1 expression

03

Biological functions

Protein translocation across endoplasmic reticulum membraneFacilitation of protein folding within the ERRegulation of unfolded protein response (UPR)Involvement in cell proliferation and immune cell infiltration (in cancer context)Recycling of the translocation apparatus
04

Disease associations

CancerOther
05

Safety considerations

Potential for off-target effects due to ubiquitous ER functionPossible disruption of basic cellular protein translocation if targeted therapeuticallyNo specific toxicities or clinical safety issues described in published sources.
06

Interacting drugs

Curcumin
07

Biomarkers

Prognostic and diagnostic biomarker for hepatocellular carcinoma (HCC)Marker for other cancers with elevated SSR1 expressionPotential marker for hepatic and gynecological cancers

Beyond the preview

Go deeper on Signal sequence receptor subunit 1 (SSR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal sequence receptor subunit 1 (SSR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call